Analyses of the protein levels showed that levels of HPGDS were significantly lower in 7 out of 10 common tumors: BRCA, colon cancer, ovarian cancer (OV), uterine corpus endometrial carcinoma (UCEC), lung cancer, head and neck cancer, and liver cancer. Here, HPGDS is linked to uterine corpus endometrial carcinoma.